Sinofn Health
Sinofn Health
At SINOFN Health Co., Ltd., we define our success through the lens of scientific rigor and nutritional intelligence. Established in 2012 and anchored by our partnership with the Chinese Academy of Sciences, we have transcended the role of a traditional ODM factory to become an innovation partner. Our expertise lies in the precise formulation of vitamins, amino acids, and specialized medical foods. We do not just manufacture; we engineer biological bioavailability, ensuring every supplement meets the highest standards of safety, efficacy, and regulatory compliance.
In a volatile global market, SINOFN leverages China's unmatched manufacturing ecosystem. By integrating upstream raw material sourcing with downstream advanced processing, we provide a "resilient supply chain." This ensures that even amidst global disruptions, our partners receive consistent supply, price stability, and rapid turnaround times. We transform raw ingredients into high-value nutraceuticals with full traceability, utilizing blockchain technology to ensure that what we promise in quality is what you receive in your final product.
The future of health is personalized. SINOFN is investing heavily in AI-driven nutrition platforms and high-throughput screening for bio-active compounds. We are moving towards "smart manufacturing," where real-time data analysis optimizes fermentation processes and enzymatic synthesis for amino acids. Our tech roadmap focuses on the next generation of bioavailability—enhancing absorption through innovative delivery systems, such as micro-encapsulation and targeted release structures.
Driven by the clinical challenges of PKU, Mrs. Liu founded SINOFN to democratize access to life-saving medical nutrition. Her legacy is one of "Profit with Purpose," ensuring that our R&D initiatives prioritize high-impact health outcomes.
Led by Dr. Tan Shengjie (Peking University) and Dr. Zhang Ying (CAS), our R&D department is staffed with masters and doctoral researchers. This academic depth allows us to solve complex formulation challenges that standard manufacturers cannot address.
Our operations are headquartered in Shanghai, with a state-of-the-art R&D and production hub in Tianjin, strategically positioned to leverage China's logistics and scientific talent pool.
Absolutely. We operate pilot-scale production lines specifically for rapid prototyping, allowing our clients to iterate formulas before moving to full-scale mass production.
Yes. We provide flexible MOQ (Minimum Order Quantity) structures and scalable service tiers, supporting early-stage brand incubation and high-volume multinational supply.
